Hester Biosciences appoints Ashish Desai as CFO
Desai is currently serving the company as Group Finance Controller
Desai is currently serving the company as Group Finance Controller
We are launching the five new products in the new manufacturing facility and they're all pharmaceuticals and this should lead to an increase in pharma numbers.
Regulatory clearance strengthens company’s global footprint and expands access to the Australian animal healthcare market
Veteran consumer health and FMCG strategist to lead preventive wellness and nutrition portfolio expansion through innovation and modern trade channels
With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical
Hospital project inaugurated by Devendra Fadnavis aims to strengthen healthcare access across North Maharashtra and nearby regions
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
The early-stage trial demonstrated an excellent safety profile alongside clinically meaningful improvements in visual acuity
Subscribe To Our Newsletter & Stay Updated